?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
    • The Issue
    • Our Solutions
  • Biosimilars 101
    • Foundations
    • Core Principles
    • FDA Regulatory Tenets
    • Biosimilars FAQs
    • Future Evolution of Biosimilar Development
    • Approved Biosimilars
  • Advocacy
    • Our Action
    • Tools
  • News
  • Resources
  • Get Involved
    • Partners

signalgroup

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
August 11, 2021 signalgroup
Biosimilars Forum Member Spotlight: 5 Questions for Organon
News
July 29, 2021 signalgroup
FDA’s Approval of First Interchangeable Biosimilar Product Paves Way for Lower Health Care Costs for Patients
News
July 15, 2021 signalgroup
Food & Drug Administration Takes Strong Enforcement Action Against Biosimilar Misinformation
News
July 9, 2021 signalgroup
President Biden’s Executive Order to Support Biosimilar Drugs Will Provide Lower Cost Options for Patients
News
July 8, 2021 signalgroup
Morning Consult: Expanding Access to Biosimilars Has Bipartisan Support. But Movement on Legislation Hangs in the Balance of the Drug Pricing Debate
News
June 30, 2021 signalgroup
Biosimilars Forum Member Spotlight: 6 Questions for Coherus
News
June 24, 2021 signalgroup
Organon Joins Biosimilars Forum
News
June 21, 2021 signalgroup
Lowering Prices with Biosimilars: ASP+8: Stakeholder Meeting Round-Up
News
June 18, 2021 signalgroup
It’s time we fulfill the ACA’s promise to broaden access to lower-cost drugs
News
June 17, 2021 signalgroup
The Biosimilars Forum Applauds SCOTUS Decision to Uphold ACA and US Pathway for Biosimilar Approval
  • Prev page
  • 05
  • 06
  • 07
  • 08
  • 09
  • Next page

  • Biosimilars 101
  • Biosimilars FAQs
  • Advocacy
  • Stay Connected
Biosimilars Forum
© 2025 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us